Guggul for Acne Treatment

Research suggests that guggul may offer meaningful benefits for acne treatment, with the available evidence generally pointing in a supportive direction. The most direct clinical evidence comes from two randomized controlled trials: a small 1994 trial found that oral gugulipid performed comparably to tetracycline in reducing nodulocystic acne lesions over three months, with patients showing oilier skin appearing to respond especially well, and a more rigorous 2025 double-blind, placebo-controlled trial of 100 participants found that a guggul-containing herbal formulation significantly reduced both inflammatory and non-inflammatory lesions while improving quality of life measures compared to placebo. A 2020 narrative review additionally synthesized broader literature on guggulipid's pharmacological properties, citing anti-inflammatory mechanisms as a plausible basis for its effects on acne. Limitations worth noting include the small sample size and age of the 1994 trial, the fact that the 2025 trial tested a combination herbal product rather than guggul in isolation making it difficult to attribute effects to guggul alone, and the absence of larger independent trials or meta-analyses to firmly establish efficacy.